AMGEN TO PRESENT AT THE BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCE

Group 1 - Amgen will present at the Bank of America Merrill Lynch Global Healthcare Conference on May 14, 2025, with key executives participating [1] - The webcast of the presentation will be available for the media, investors, and the public, and will be archived for at least 90 days [2] Group 2 - Amgen is a leader in biotechnology, focusing on innovative medicines for serious diseases, with a strong pipeline targeting cancer, heart disease, osteoporosis, inflammatory diseases, and rare diseases [3] - In 2024, Amgen received recognition as one of the "World's Most Innovative Companies" and "America's Best Large Employers," and is part of the Dow Jones Industrial Average and Nasdaq-100 Index [4]